Genomic medicine has entered the clinical space and is expected to grow exponentially as technology costs decrease and the evidence informing the practice of personalized medicine continues to grow.

Practitioners attending the conference can expect to learn the following.

  1. Apply basic human genetics terminology to clinical practice
  2. Describe how the identification of disease-associated genetic variations facilitates development of prevention, diagnosis and treatment options.
  3. Formulate a strategy for genomic testing that integrates family history, patient preference and clinical needs.
  4. Discuss the potential physical and psychosocial benefits, limitations and risks of genetic information for individuals, family members and communities.
  5. Distinguish the capabilities and limitations of different technology platforms and how they apply to clinical genomic testing.
  6. Describe the utility of genomic medicine for non-critically ill patients and why it genomic testing can be beneficial to those individuals.
  7. Critically interpret genomic test results, recognizing the distinction between clinically significant findings, secondary findings, variants of unknown significance and benign variants.
  8. Summarize best practices in the delivery of genomic test results to patients and families.
  9. Discuss the current landscape of reimbursement, insurance and the law as it pertains to coverage and genomic medicine (GINA protection, life insurance, long-term disability).